...
首页> 外文期刊>Biochemical and Biophysical Research Communications >Downregulating the expression of heparanase inhibits the invasion, angiogenesis and metastasis of human hepatocellular carcinoma
【24h】

Downregulating the expression of heparanase inhibits the invasion, angiogenesis and metastasis of human hepatocellular carcinoma

机译:下调乙酰肝素酶的表达抑制人肝细胞癌的侵袭,血管生成和转移

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Invasion and metastasis are key features of human hepatocellular carcinoma (HCC). Heparanase is an endoglycosidase that can degrade extracellular matrix by cleaving heparan sulfate chains of heparan sulfate proteoglycan, thus playing important roles in the invasion and metastasis of human cancers. Heparanase has been detected in various human cancers and regarded as a prospective target in human cancer treatments. However, the effects of inhibiting the expression of heparanase on human HCC have not been fully evaluated. In this article we show that downregulating the expression of heparanase either by antisense oligodeoxynucleotide or by RNA interferencing can significantly reduce the expression of heparanase in SMMC7721 human HCC cells, leading to inhibition of the invasiveness, metastasis, and angiogenesis of HCC cells both in vitro and in vivo. Our results suggest that genetic downregulation of the expression of heparanase may serve as an efficient cancer therapeutic for human HCC. (c) 2007 Elsevier Inc. All rights reserved.
机译:侵袭和转移是人类肝细胞癌(HCC)的关键特征。乙酰肝素酶是一种内切糖苷酶,可通过裂解硫酸乙酰肝素蛋白聚糖的硫酸乙酰肝素链来降解细胞外基质,从而在人类癌症的侵袭和转移中发挥重要作用。乙酰肝素酶已在多种人类癌症中被检测到,并被视为人类癌症治疗中的潜在靶标。但是,尚未完全评估抑制乙酰肝素酶表达对人HCC的作用。在本文中,我们表明通过反义寡聚脱氧核苷酸或RNA干扰来下调乙酰肝素酶的表达可显着降低SMMC7721人HCC细胞中乙酰肝素酶的表达,从而抑制肝癌在体外和体外的侵袭性,转移和血管生成。体内。我们的结果表明,乙酰肝素酶表达的基因下调可以作为人类HCC的有效癌症治疗剂。 (c)2007 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号